Back to explore

RV014

Research Fellow

11 Assessments Completed

PublicationDateOverall AssessmentActions

Randomized Trial of a Group Music and Imagery Method (GrpMI) for Women with Fibromyalgia

10.1093/jmt/thy005

5 Nov 2025Some concernsView

Mindfulness Meditation Alleviates Fibromyalgia Symptoms in Women: Results of a Randomized Clinical Trial

10.1007/s12160-014-9665-0

5 Nov 2025Some concernsView

Benefits of adding stretching to a moderate-intensity aerobic exercise programme in women with fibromyalgia: a randomized controlled trial

10.1177/0269215519893107

5 Nov 2025No concernsView

A randomised controlled trial of the 5:2 diet

10.1371/journal.pone.0258853

5 Nov 2025No concernsView

A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial

10.1016/s0140-6736(13)62420-4

5 Nov 2025No concernsView

Transformative tales: The role of story videos on children's reasoning about transgender identities

10.1111/bjdp.12503

5 Nov 2025Some concernsView

Human cold pain: a randomized crossover trial

10.1097/j.pain.0000000000003503

5 Nov 2025No concernsView

Does Increased Consolidated Nighttime Sleep Facilitate Attentional Control? A Pilot Study of Nap Restriction in Preschoolers

10.1177/1087054715569281

5 Nov 2025Some concernsView

Clinical Trial on the Effects of Vitamin D Supplementation on Metabolic Profiles in Diabetic Hemodialysis

10.1055/s-0043-119221

4 Nov 2025Serious concernsView

A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes

10.1016/j.jacl.2015.12.017

4 Nov 2025Serious concernsView

The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial

10.1016/j.pnpbp.2018.02.007

4 Nov 2025Serious concernsView